Mirae Asset Global Etfs Holdings Ltd. Elevation Oncology, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Elevation Oncology, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 26,688 shares of ELEV stock, worth $16,813. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,688Holding current value
$16,813% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ELEV
# of Institutions
68Shares Held
45MCall Options Held
700Put Options Held
27.6K-
Frazier Life Sciences Management, L.P. Menlo Park, CA5.99MShares$3.78 Million0.19% of portfolio
-
Tang Capital Management LLC San Diego, CA4.76MShares$3 Million0.24% of portfolio
-
Goldman Sachs Group Inc New York, NY3.99MShares$2.51 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.53MShares$2.22 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.07MShares$1.94 Million0.0% of portfolio
About Elevation Oncology, Inc.
- Ticker ELEV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,300,900
- Market Cap $14.7M
- Description
- Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...